Feature

Target the Right Cell,

at Every Stage of Dementia.

​Our platform enables comprehensive drug efficacy evaluation across the entire spectrum of dementia progression

from single cell type cultures to dual and triculture systems allowing precise assessment of target cell responses at each disease stage​

Assay

Visualize. Analyze. Validate.

Our platform enables real-time cellular imaging to capture neural dynamics, analyzes cell-secreted factors through conditioned media, 

and validates specific marker expression via immunofluorescence staining.

Live cell imaging

Conditioned media

Immunostaining

Our platform enables real-time morphological analysis to assess cellular activation and track microgliosis, while calcium imaging allows visualization of neurodynamics in live cultures.

Pathological responses are further evaluated by analyzing cell-secreted factors using ELISA and multiplex cytokine assays.

Drug-targeted molecules and proteins are visualized through immunostaining, enabling comparative analysis of diverse marker expression patterns across treatment conditions.

Publication

Recognized on the Cover of Scientific Journals.

Our platform has demonstrated scientific excellence and reliability, being featured in leading scientific journals.